Clorox Stock Rockets 9.5% With 5-Day Winning Streak
Clorox (CLX) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 9.5% return. The company has gained about $1.1 Bil in value over the last 5 days, with its current market capitalization at about $13 Bil. The stock remains 31.2% below its value at the end of 2024. This compares with year-to-date returns of 15.8% for the S&P 500.
Clorox’s recent surge reflects investor optimism as its Q1 EPS beat estimates despite ERP transition headwinds. Management’s confident H2 outlook and a significant director stock purchase underscored belief in future organic sales growth and robust margins post-system rollout.
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. Our take: There are several things to fear in CLX stock given its overall Weak operating performance and financial condition. This isn’t appropriately reflected in the stock’s Moderate valuation which is why we think it is Unattractive (see Buy or Sell CLX).
For quick background, CLX provides consumer and professional products globally across health, household, lifestyle, and international segments, primarily sold through mass retailers, grocery outlets, warehouse clubs, dollar stores, and hardware centers.
Comparing CLX Stock Returns With The S&P 500
The following table summarizes the return for CLX stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | CLX | S&P 500 |
|---|---|---|
| 1D | 0.8% | 0.7% |
| 5D (Current Streak) | 9.5% | 2.6% |
| 1M (21D) | -6.5% | -1.1% |
| 3M (63D) | -7.7% | 4.8% |
| YTD 2025 | -31.2% | 15.8% |
| 2024 | 17.7% | 23.3% |
| 2023 | 5.0% | 24.2% |
| 2022 | -17.0% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 136 S&P constituents with 3 days or more of consecutive gains and 8 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 20 | 7 |
| 4D | 94 | 0 |
| 5D | 14 | 0 |
| 6D | 3 | 0 |
| 7D or more | 5 | 1 |
| Total >=3 D | 136 | 8 |
Key Financials for Clorox (CLX)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $7.1 Bil | $7.1 Bil |
| Operating Income | $723.0 Mil | $1.2 Bil |
| Net Income | $280.0 Mil | $810.0 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ4 | 2026 FQ1 |
|---|---|---|
| Revenues | $2.0 Bil | $1.4 Bil |
| Operating Income | $420.0 Mil | $120.0 Mil |
| Net Income | $332.0 Mil | $80.0 Mil |
While CLX stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.